Patents by Inventor Thomas Blattler

Thomas Blattler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION COMPRISING VLP AND AMYLOID BETA PEPTIDE
    Publication number: 20140079730
    Abstract: The present invention relates to novel uses of a construct consisting of virus-like particle (VLP) structure chemically coupled to a fragment of the A?-1-42 peptide and its pharmaceutically acceptable salts (hereinafter CONSTRUCT), in particular to dosage regimens, modes of and dosage forms for the administration of a CONSTRUCT for the treatment of patients suffering from dementia.
    Type: Application
    Filed: November 20, 2013
    Publication date: March 20, 2014
    Applicant: NOVARTIS AG
    Inventors: Ana GRAF, Matthias STAUFENBIEL, Thomas BLÄTTLER, Paolo PAGANETTI
  • COMPOSITION COMPRISING VLP AND AMYLOID BETA PEPTIDE
    Publication number: 20130252889
    Abstract: The present invention relates to novel uses of a construct consisting of virus-like particle (VLP) structure chemically coupled to a fragment of the AD-1-42 peptide and its pharmaceutically acceptable salts (hereinafter CONSTRUCT), in particular to dosage regimens, modes of and dosage forms for the administration of a CONSTRUCT for the treatment of patients suffering from dementia.
    Type: Application
    Filed: May 13, 2013
    Publication date: September 26, 2013
    Applicant: Novartis AG
    Inventors: Ana GRAF, Matthias STAUFENBIEL, Thomas BLÄTTLER, Paolo PAGANETTI
  • Composition comprising VLP and amyloid beta peptide
    Patent number: 8460676
    Abstract: The present invention relates to uses of a construct consisting of virus-like particle (VLP) structure chemically coupled to a fragment of the A?-1-42 peptide and its pharmaceutically acceptable salts (hereinafter CONSTRUCT), in particular to dosage regimens, modes of and dosage forms for the administration of a CONSTRUCT for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: June 11, 2013
    Assignee: Novartis AG
    Inventors: Ana Graf, Matthias Staufenbiel, Thomas Blättler, Paolo Paganetti
  • COMPOSITION COMPRISING VLP AND AMYLOID BETA PEPTIDE
    Publication number: 20110086036
    Abstract: The present invention relates to novel uses of a construct consisting of virus-like particle (VLP) structure chemically coupled to a fragment of the A?-1-42 peptide and its pharmaceutically acceptable salts (hereinafter CONSTRUCT), in particular to dosage regimens, modes of and dosage forms for the administration of a CONSTRUCT for the treatment of patients suffering from dementia, in particular dementia of the A
    Type: Application
    Filed: December 17, 2010
    Publication date: April 14, 2011
    Inventors: Ana Graf, Matthias Staufenbiel, Thomas Blättler, Paolo Paganetti
  • Methods of treating dementia by administering virus-like particles coupled to A?
    Patent number: 7867499
    Abstract: The present invention relates to novel uses of a construct consisting of virus-like particle (VLP) structure chemically coupled to a fragment of the A?-1-42 peptide and its pharmaceutically acceptable salts (hereinafter CONSTRUCT), in particular to dosage regimens, modes of and dosage forms for the administration of a CONSTRUCT for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type.
    Type: Grant
    Filed: November 3, 2005
    Date of Patent: January 11, 2011
    Assignee: Novartis AG
    Inventors: Ana Graf, Matthias Staufenbiel, Thomas Blättler, Paolo Paganetti
  • COMPOSITION OF ORGANIC COMPOUNDS
    Publication number: 20090060899
    Abstract: The present invention relates to novel uses of a construct consisting of virus-like particle (VLP) structure chemically coupled to a fragment of the A?-1-42 peptide and its pharmaceutically acceptable salts (hereinafter CONSTRUCT), in particular to dosage regimens, modes of and dosage forms for the administration of a CONSTRUCT for the treatment of patients suffering from dementia, in particular dementia of the A
    Type: Application
    Filed: November 3, 2005
    Publication date: March 5, 2009
    Inventors: Ana Graf, Matthias Staufenbiel, Thomas Blattler, Paolo Paganetti